Atlas Trials

Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes

Clinical trial NCT04307797 · COMPLETED

Trial details

NCT number
NCT04307797
Sponsor
Cambridge University Hospitals NHS Foundation Trust
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 DiabetesObesity
Start date
2022-01-18
Primary completion
2022-10-07
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.